Edmund Harrigan is the current Director at PhaseBio. Edmund has over 17 years of experience in the pharmaceutical industry, holding various leadership positions at prestigious companies. Edmund started their career at Pfizer in 2003, where they worked their way up to Senior Vice President before leaving in 2015. After a brief stint at Neurogen Corporation as Executive Vice President, Edmund became Senior Vice President at Sepracor in 2001. In 2011, Edmund became Director at Karuna Pharma, where they stayed until 2020. Most recently, Edmund was Director at Bellicum Pharmaceuticals from 2018 to 2019. Edmund has been working at PhaseBio since 2016 and was promoted to Director in 2019.
Edmund Harrigan graduated from Saint Anselm College with a BA in Chemistry. Edmund then attended UMass Chan Medical School and earned their MD.